Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies

Dateline City: KENILWORTH, N.J. & LYON, France KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage their product portfolios and pursue their own distinct growth strategies in Europe. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestor:Justin Holko, 908-740-1879orSanofi PasteurMedia:Alain Bernal, +33 4 37 37 50 38orInvestor:Sébastien Martel, +33 1 53 77 45 45 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Tags: Vaccine News Corporate News Latest News #Merck #MRK $MRK MSD NYSE:MRK Sanofi Pasteur Source Type: news